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          I  ntroduction 
  Obesity is rapidly becoming a worldwide epidemic, leading to 
numerous medical conditions such as type 2 diabetes and cardio-
vascular disease. The development of obesity is marked by both 
an increase in adipocyte size and number as a consequence of 
differentiation of the stem cells or preadipocytes into mature 
adipocytes (for review see   Gesta et al., 2007  ). Spontaneous dif-
ferentiation of embryonic stem (ES) cells into adipocytes in cul-
ture is a rare event; thus, for ES cells to commit toward the 
adipocyte lineage, it is necessary to pretreat cells with retinoic 
acid (RA), a ligand of the nuclear receptor retinoid X receptor 
(RXR), during the fi  rst phase of differentiation (  Dani et al., 
1997  ). RXR in response to RA heterodimerizes with peroxi-
some proliferator  –  activated receptor (PPAR), resulting in acti-
vation of genes involved in terminal differentiation and lipid 
metabolism (  Gregoire et al., 1998  ). PPAR   2,  CCAAT  en-
hancer – binding  protein      (C/EBP   ), and aP2 are crucial for the 
development of adipose cells (  Rosen et al., 2000  ). The process 
of adipogenesis may also be infl  uenced by different extrinsic 
factor and intracellular signaling pathways (  Rosen and Mac-
Dougald, 2006  ), yet very little is known about the role of Ca 
2+  
homeostasis in adipogenesis. Increased Ca 
2+   levels lead to in-
hibition of adipocyte differentiation, which is accompanied by 
the decrease or, in some cases, the loss of PPAR   2,  C/EBP  , 
and aP2 expression (  Jensen et al., 2004  ;   Serlachius and Andersson, 
2004  ;   Zhang et al., 2007  ). Thapsigargin, an inhibitor of the 
sarco/ER Ca 
2+  -ATPase, inhibits adipocyte differentiation in 
3T3-L1 preadipocytes (  Ntambi and Takova, 1996  ;   Shi et al., 
2000  ), suggesting a role for ER stores and ER Ca 
2+ -binding  pro-
teins in the modulation of adipogenesis. 
  Calreticulin is a major Ca 
2+  -buffering protein in the lu-
men of the ER, which also acts as a molecular chaperone and 
modulator of gene expression (  Bedard et al., 2005  ). The two 
major functions of calreticulin, chaperoning and Ca 
2+   buffer-
ing, are confi  ned to specifi  c protein domains. The N+P domain 
of calreticulin forms a folding module, and the acidic C-terminal 
C domain binds and buffers Ca 
2+   with high capacity (  Baksh 
and Michalak, 1991  ;   Nakamura et al., 2001  ). Calreticulin de-
fi  ciency is embryonic lethal (  Mesaeli et al., 1999  ), and calre-
ticulin-defi  cient cells have a reduced capacity for Ca 
2+   storage 
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  Results 
  Calreticulin deﬁ  ciency promotes 
adipogenesis 
    Fig. 1   A shows that the adipogenic potential of ES cells, as 
measured by oil red O staining at differentiation day 20 (D20), 
was     30-fold higher in the absence of calreticulin. The num-
ber of adipocyte colonies in calreticulin-deficient embryoid 
bodies (EBs) was approximately ninefold higher than that 
in the calreticulin-containing EBs at D20 (  Fig. 1 B  ). This was 
irrespective of whether the calreticulin gene was removed 
by homologous recombination (G45  crt  
   /     cells) or by Cre 
within the ER and impaired agonist-stimulated Ca 
2+   release 
from ER stores, whereas cells overexpressing calreticulin have 
higher levels of lumenal ER Ca 
2+   and a larger pool of releasable 
Ca 
2+   (  Nakamura et al., 2001  ). Calreticulin  ’  s impact on protein 
folding and Ca 
2+   homeostasis have been implicated in several 
signaling pathways (  Bedard et al., 2005  ), thus affecting gene 
expression and, consequently, the behavior of individual cells 
and cell communities. In this study, we show that calreticulin 
may act as a Ca 
2+  -dependent molecular switch that negatively 
regulates commitment to adipocyte differentiation by prevent-
ing the expression and transcriptional activation of critical pro-
adipogenic transcription factors. 
  Figure 1.       Adipogenesis increases in calreticulin-deﬁ  cient EBs.   Oil red O is a lysochrome used for staining triglycerides and some lipoproteins, 
thus being useful in visualizing the degree of adipogenesis. (A) At D20, calreticulin-deﬁ   cient ES cells (G45  crt   
    /      and L7  crt   
    /     ) stained more 
extensively with oil red O than WT cells (P   <   0.01;   n   = 6) and made more adipocyte colonies (P   <   0.01;   n   = 5) (B). (C) The ES cells lacking 
calreticulin (G45  crt   
    /      and L7  crt   
    /     ) showed an increase in expression of PPAR    2, C/EBP     (by Western blotting), and aP2 (by PCR) compared 
with the WT or L7 cells. Relative protein levels were determined by normalizing the calreticulin, PPAR    2, and C/EBP     to GAPDH, and aP2 
mRNA levels were normalized with the housekeeping gene L32. (D) Quantitative analysis of the relative expression of adipogenic markers at D20 
(P   <   0.01;   n   = 6). (E) Oil red O staining and Western blot analysis with anticalreticulin (CRT) antibodies of 3T3-L1 preadipocytes and 3T3-L1 cells 
overexpressing calreticulin (3T3-L1 + CRT). 3T3-L1 cell ﬁ  broblasts overexpressing calreticulin showed reduced oil red O staining. (F) RT-PCR show-
ing that adipogenic marker expression decreased in 3T3-L1 + CRT cells overexpressing calreticulin compared with control 3T3-L1 cells. Error bars 
represent SD.     105 CALRETICULIN MODULATES ADIPOGENIC COMMITMENT   • Szabo et al. 
calreticulin-defi  cient and calreticulin-containing cells, which 
makes it diffi  cult to visualize all of them when equally loaded. 
Modulation of the expression of calreticulin also impacted adipo-
genesis of 3T3-L1 preadipocytes, a commonly used model 
for adipogenesis (  Otto and Lane, 2005  ). Increased expression 
of calreticulin in 3T3-L1 preadipocytes inhibited their adipo-
genesis, as indicated by oil red O staining (  Fig. 1 E  ). In agree-
ment with ES cell results, molecular markers of adipogenesis 
(lipoprotein lipase, aP2, PPAR   2,  C/EBP  ,  and  C/EBP  )  were 
all down-regulated in 3T3-L1 cells overexpressing calreticulin 
( Fig.  1  F ). 
  Upon induction of adipogenesis with RA, the abun-
dance of calreticulin increased dramatically in the WT ES cells 
(  Fig. 2 A  ), whereas the abundance of PPAR    2 and C/EBP    
remained persistently low (  Fig. 2, B and C  ). In contrast, in 
calreticulin-defi  cient (G45  crt  
   /    ) cells after induction of adipo-
genesis with RA, PPAR   2  and  C/EBP    levels steadily in-
creased over 20 d of differentiation (  Fig. 2, B and C  ). Similar 
to the WT ES cells, the 3T3-L1 preadipocytes and 3T3-L1 
cells overexpressing calreticulin showed an increase in calre-
ticulin abundance and reduced adipogenic potential upon 
RA treatment (  Fig. 2, D and E  ). We concluded that the in-
creased expression of calreticulin plays a negative regulatory role 
during adipogenesis. 
 recombinase – mediated excision (L7 crt  
   /    cells; Fig. S1 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200712078/DC1). 
Adipogenesis in ES cells was RA and insulin dependent and re-
quired an initial 3-d exposure to RA followed by insulin treat-
ment (unpublished data). Microscopically, by Nile red staining, 
lipid droplets in the wild-type (WT) adipocytes were indistin-
guishable from those in calreticulin-defi  cient cells (Fig. S1 B), 
indicating that the gross morphology of lipid stores was not af-
fected in the absence of calreticulin. Nile red is a red-emitting 
fl  uorescent lysochrome (  Greenspan et al., 1985  ) that can be 
used as a fl  uorescent alternative to oil red O lipid visualization 
(  Fowler and Greenspan, 1985  ). Fig. S2 shows the nucleotide 
sequence of the calreticulin promoter. 
  Next, we examined the expression of both early (C/EBP    
and PPAR    2) and late (aP2) adipogenic markers. The abun-
dance of PPAR   2  and  C/EBP    adipogenesis markers was 
markedly increased at D20 in G45  crt 
   /       and  L7 crt 
   /       cells 
compared with WT (  Fig. 1, C and D  ). The aP2 mRNA lev-
els were undetectable in extracts from the WT and L7 cells, 
whereas they were high at D20 in extracts from calreticulin-
defi  cient cells (  Fig. 1, C and D  ). It should be stressed that in 
  Fig. 1 C   as well as in subsequent fi  gures, adipogenic markers 
in calreticulin-containing cells are barely discernible. This is 
caused by a large disparity in the markers  ’   abundance between 
  Figure 2.       Calreticulin, PPAR    2, and C/EBP     levels in-
crease over the 20-d differentiation time line, whereas 
overexpression of calreticulin inhibits adipogenesis.   
(A  –  C) Calreticulin (CRT), PPAR    2, and C/EBP     ex-
pression was examined in WT and G45  crt   
    /      cells 
by Western blotting over 20 d of adipocyte differen-
tiation as described in Materials and methods. The 
arrows represent the addition of retinoic acid (RA) or 
insulin (Ins) and TIT (triiodothyronine). (A) 10 
    7   M RA 
treatment of cells during the ﬁ  rst 3 d of differentiation 
induced calreticulin expression in WT cells. (B and C) 
Expression of PPAR    2 and C/EBP     in RA-treated 
  crt   
    /      cells gradually increased, whereas their levels 
in WT cells remained low over the 20-d differen-
tiation. Standard error bars in A  –  C are smaller than 
the symbols. RA treatment up-regulates calreticulin in 
3T3-L1 cells. (D) Western blot analysis with anti-HA anti-
bodies of 3T3-L1 preadipocytes (3T3-L1 control) and 
3T3-L1 cells overexpressing HA-tagged calreticulin 
(3T3-L1 + CRT) show a marked increase in calreticulin 
levels after RA treatment. (E) 3T3-L1 cells treated with 
RA show a decrease in oil red O staining, whereas 
overexpression of calreticulin reduced the staining fur-
ther. Error bars represent SD.     JCB • VOLUME 182 • NUMBER 1 • 2008  106
or L7  crt 
   /      ;   Fig. 3, A and B  ). In contrast, after treatment with 
ionomycin, there was no detectable oil red O  –  positive adipo-
cytes derived from WT and L7 cells, whereas differentiation of 
both calreticulin-defi  cient cell lines (G45  crt 
   /       and  L7 crt 
   /     ) 
produced an extremely low number of oil red O  –  positive cells 
(  Fig. 3, A and B  ). 
  In agreement with oil red O staining results, BAPTA-AM 
treatment signifi  cantly increased the abundance of all three adipo-
genic markers in adipocytes derived from WT and L7 cells 
containing calreticulin but did not have a signifi  cant effect 
on adipocytes derived from calreticulin-defi  cient (G45  crt  
   /     and 
L7  crt  
   /   ) ES cells ( Fig. 3, C and D ). In the presence of ionomycin, 
the levels of PPAR   2,  C/EBP   , and aP2 remained nearly un-
detectable in extracts from WT and L7 cells (  Fig. 3, C and E  ). How-
ever, ionomycin signifi  cantly decreased the abundance of PPAR   2, 
C/EBP    , and aP2 levels in extracts from calreticulin-defi  cient cell 
lines (G45  crt 
   /       and L7  crt 
   /      ) at D20 (  Fig. 3, C and E  ). 
  Changes in the intracellular Ca 
2+   
concentration affect adipogenesis 
  One important function of calreticulin is modulation of Ca 
2+  
homeostasis (  Nakamura et al., 2001  ;   Bedard et al., 2005  ). Thus, 
we next examined whether calreticulin-dependent changes in 
Ca 
2+   homeostasis might be responsible for modulation of adipo-
genesis. We used BAPTA-AM, a membrane-permeable Ca 
2+  
chelator (  Tsien, 1980  ), to lower cytosolic Ca 
2+   concentration 
([Ca 
2+ ] Cyto  ) as well as ionomycin, a Ca 
2+   ionophore  ( Bergling  et  al., 
1998  ), to increase [Ca 
2+ ] Cyto  . Treatment of cells with BAPTA 
from 20 min to 2 h produced exactly the same results (unpub-
lished data), which implies that BAPTA was not secreted from 
the cells. BAPTA-AM  –  treated WT and L7 cells showed a dra-
matic increase in oil red O staining, indicating that chelation of 
cytoplasmic Ca 
2+   promoted adipogenesis in these cells (  Fig. 3, 
A and B ). There was no signifi  cant increase in oil red O staining in 
BAPTA-AM – treated  calreticulin-defi  cient ES cells (G45  crt 
   /      
  Figure 3.       Changes in intracellular Ca 
2+   concentration affect adipogenesis.   BAPTA-AM, a membrane-permeable Ca 
2+   chelator, was used to lower cytosolic Ca 
2+   
concentration, whereas a Ca 
2+   ionophore, ionomycin, was used to increase it. (A) WT and L7 ES cells showed increased oil red O staining after treatment 
with BAPTA-AM, whereas no substantial change in the staining was discernible in calreticulin-deﬁ  cient ES cells (G45  crt   
    /      and L7  crt   
    /     ). Ionomycin treatment 
decreased oil red O staining in calreticulin-deﬁ  cient cells. (B) Colorimetric assay of oil red O staining in the ES cells treated as in A (  n   = 6). (C) Treatment with 
BAPTA-AM increased the expression of PPAR    2, C/EBP    , and aP2 in WT or L7 ES cell lines. Conversely, ionomycin treatment decreased the adipogenic marker 
expression in calreticulin-deﬁ  cient (G45  crt   
    /      and L7  crt   
    /     ) cells. (D) Quantitative analysis of relative adipogenic marker expression after BAPTA-AM treatment 
(P   <   0.01;   n   = 6). (E) Quantitative analysis of relative adipogenic marker expression after ionomycin treatment (P   <   0.01;   n   = 6). Error bars represent SD.     107 CALRETICULIN MODULATES ADIPOGENIC COMMITMENT   • Szabo et al. 
  Figure 4.      Expression of the P+C domains of calreticulin reduces adipogenesis.   (A) A schematic of the structural and functional calreticulin domains as well as Western blot analysis 
(with anti-HA antibodies) of G45  crt   
    /      ES cells expressing the N+P and P+C domain of calreticulin. (B) Oil red O staining in WT, G45  crt   
    /     , and G45  crt   
    /      ES cells express-
ing P+C and N+P domains. G45  crt   
    /     cells expressing the P+C domain had decreased staining compared with the G45  crt   
    /      cells. When the cells were treated with 50 nM 
BAPTA-AM, both the P+C domain –  expressing and WT ES cells showed a dramatic increase in oil red O staining. The N+P domain –  expressing ES cells had oil red O staining similar 
to that of the G45 crt   
    /      ES cells. When the cells were treated with 500 nM ionomycin, both the N+P domain –  containing and G45 crt   
    /      ES cells showed a decrease in oil red O 
staining. (C) Expression of the P+C domain in 3T3-L1 cells (3T3-L1 + [P+C]) reduced oil red O staining. Because 3T3-L1 is used as a control, it is always counted as 1. Expression 
of the P+C domain was conﬁ  rmed using HA antibody. (D) Adipogenic marker expression was decreased in the P+C domain –  containing G45 crt   
    /      cells when compared with 
the G45  crt   
    /      cells (P   <   0.01;   n   = 6) and was comparable to that in WT cell levels (P   >   0.05). BAPTA-AM treatment increased adipogenic marker expression in all cell lines 
(  n   = 6). (E) Adipogenic marker expression was higher in the N+P domain  –  expressing G45  crt   
    /      cells than in the WT ES cells (P   <   0.01;   n   = 6) and was similar to that in 
G45  crt   
    /      cell levels (P   >   0.05). Ionomycin treatment reduced adipogenic marker expression in all cell lines (  n   = 6). (F)  
45  Ca 
2+  -loaded ES cells were treated with thapsi-
gargin or ionomycin to measure ER-releasable and total [Ca 
2+  ], respectively. WT and P+C domain  –  expressing G45  crt   
    /      cells had higher [Ca 
2+  ]  ER   and [Ca 
2+  ]  Tot   than the 
G45  crt   
    /      cells (  n   = 3). (G) Fura-2-AM  –  loaded ES cells were treated with thapsigargin to measure ER-releasable and cytosolic [Ca 
2+  ]. WT and P+C domain  –  expressing 
G45  crt   
    /      cells had higher [Ca 
2+  ]  ER   and higher cytosolic [Ca 
2+  ] than the G45  crt   
    /      cells (  n   = 3). (H)  
45  Ca 
2+  -loaded 3T3-L1 cells were treated with thapsigargin or ionomycin 
to measure [Ca 
2+  ]  ER   and [Ca 
2+  ]  Tot   levels. 3T3-L1 + CRT cells (overexpressing calreticulin) and 3T3-L1 expressing the P+C domain had higher [Ca 
2+  ]  Tot   and [Ca 
2+  ]  ER   than the 
control 3T3-L1 cells (  n   = 3). Error bars represent SD.     JCB • VOLUME 182 • NUMBER 1 • 2008  108
  Figure 5.       PPAR     activates the calreticulin gene.   (A) A schematic representation of reporter plasmids used in this study. The calreticulin promoter (pLCC0) 
contains two PPRE sites: PPRE1 (    1,944 bp) and PPRE2 (    590 bp). Two promoter deletion constructs (pLC1 and pLC2) and two promoter constructs, one 
containing a mutation of PPRE1 (pLC0mt1) and the other containing a mutation of PPRE2 (pLC0mt2), were used to identify PPRE sites activated by PPAR     on 
the calreticulin promoter. (B) To analyze the effect of PPAR     and RXR     on the calreticulin promoter, NIH3T3 cells were transiently cotransfected with the PPAR     
and RXR     expression plasmids with a luciferase reporter gene controlled by the calreticulin promoter as indicated in A. Individual controls were obtained 
for each expression plasmid, and data were plotted relative to that control (luciferase/    -galactosidase). The data shown are mean   ±   SD (error bars) of three 
independent experiments. (C) EMSA analysis was performed to demonstrate the binding of PPAR     to the PPRE1 and PPRE2 elements on calreticulin promoter. 
The positions of PPAR      –  RXR      –  DNA complexes are indicated. White lines indicate that intervening lanes have been spliced out. (D) Supershift EMSA analysis 
of PPAR     binding to the PPRE1 and PPRE2 elements on calreticulin promoter using anti-HA tag antibody was used to show the binding of transcriptional factor 
to the DNA element. Mutated PPRE1 and PPRE2 oligonuleotide show no interaction with PPAR    . Arrows mark PPAR     complexes with either PPRE1 or PPRE2. 
(E) ChIP analysis of a putative PPAR    -binding site in the mouse calreticulin promoter was used to show binding of PPAR     to the endogenous calreticulin 
promoter. Lane 1 shows input DNA, lane 2 is a negative control without antibody treatment, and lane 3 shows ChIP with antibodies.     
  Modulation of adipogenesis by functional 
modules of calreticulin 
  Calreticulin has two structural and functional domains (  Nakamura 
et al., 2001  ); one responsible for chaperoning, and another for 
Ca 
2+   buffering (  Fig. 4 A  ). To determine which of calreticulin  ’  s 
functions (domains) may be involved in the modulation of adipo-
genesis, two ES cell lines expressing single functional mod-
ules of calreticulin in calreticulin-defi  cient ES cells (G45  crt  
   /   ) 
were created and tested for adipogenic potential. Because the 
C domain of calreticulin cannot be stably maintained, it was 
fused to the P domain of calreticulin (  Nakamura et al., 2001  ). 
Expression of the domains was tracked using anti-HA anti-
bodies (  Fig. 4 A  ). 
    Fig. 4 B   shows that reexpression of the P+C domain in 
calreticulin-defi  cient cells inhibited adipogenesis ( Fig. 4, B and D ). 
Overexpression of the P+C domain in 3T3-L1 preadipocytes 
also resulted in reduced adipogenesis (  Fig. 4 C  ). Treatment of 
the P+C domain  –  expressing   crt 
   /       ES cells with BAPTA-AM 
restored their adipogenic potential (  Fig. 4, B and D  ). In contrast, 
expression of the N+P domain in   crt 
   /       ES cells had no signifi  -
cant effect on their ability to differentiate into adipocytes, and 
they maintained a phenotype identical to calreticulin-defi  cient 109 CALRETICULIN MODULATES ADIPOGENIC COMMITMENT   • Szabo et al. 
calreticulin or the P+C domains in the 3T3-L1 preadipocytes 
also resulted in increased [Ca 
2+ ] ER   and [Ca 
2+ ] Tot   compared 
with control 3T3-L1 cells (  Fig. 4 H  ). Finally, as ionomycin may 
be inactive in releasing Ca 
2+   from acidic intracellular com-
partments, we added the sodium proton ionophore monensin. 
Monensin-induced Ca 
2+   release was very small (unpublished 
data), suggesting that WT,   crt 
   /       cells, and cells expressing the 
N+P domain did not contain substantial quantities of Ca 
2+  
stored within acidic compartments. Thus, we conclude that the 
effects of calreticulin on adipogenesis may be mediated by cal-
reticulin-dependent changes in intracellular Ca 
2+ . 
  Functional relationship between calreticulin 
and PPAR    2 
  The results so far suggested that calreticulin plays a modula-
tory role during adipogenesis. We next wanted to determine 
whether there was a functional relationship between calre-
ticulin and the PPAR     transcriptional complex. Upon RA-
dependent induction of adipogenesis, RXR and PPAR     form  a 
transcriptionally active complex. The calreticulin promoter 
contains two PPAR    -binding sites termed peroxisome prolif-
erator responsive elements (PPREs); one is found at    1,944  bp 
(designated PPRE1), and the other is found at    590  bp  (des-
ignated PPRE2;   Fig. 5 A  ), suggesting that the PPAR     tran-
scription factor may regulate the calreticulin gene. To test 
this, NIH3T3 fi  broblasts were cotransfected with PPAR     ex-
pression vector and RXR     expression vector (pLC0, pLC1, 
pLC2, pLC0mt1, and pLC0mt2) or luciferase reporter gene 
vectors (pCL2 and pCL3;   Fig. 5 A  ) under control of the cal-
reticulin promoter. pSV    -galactosidase was used as an inter-
nal control. In the pLC0 vector, luciferase was controlled by 
2.1 kb of the calreticulin promoter containing both PPRE sites 
( Fig. 5 A  and Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200712078/DC1).   Fig. 5 B   shows that PPAR     induced 
luciferase activity in NIH3T3 cells. Cells transfected with 
cells (  Fig. 4 B  ). This was further supported by BATPA-AM and 
ionomycin experiments (  Fig. 4  ), indicating that the chaperone 
function of calreticulin was not involved in the modulation of 
adipogenesis. Therefore,  crt 
   /       cells expressing the N+P domain 
of calreticulin displayed features resembling those of   crt 
   /       ES 
cells, whereas   crt  
   /     cells expressing the Ca 
2+ -buffering  region 
of the protein (P+C domain) had properties characteristic of 
those of WT cells, indicating that calreticulin modulates adipo-
genesis via its Ca 
2+   homeostatic  function. 
  To assess whether the Ca 
2+   content of intracellular Ca 
2+  
stores is modifi  ed in   crt 
   /       cells and calreticulin-defi  cient cells 
expressing Ca 
2+   handling the P+C domain of calreticulin, we 
performed equilibrium loading experiments with  
45 Ca 
2+ .  Cells 
were cultured for 54 h in the regular culture medium containing 
10 mCi/ml  
45 Ca 
2+  . The total cellular Ca 
2+   content was then cal-
culated based on the cell-associated radioactivity and on the 
specifi  c activity of Ca 
2+   in the culture medium. We used thapsi-
gargin, an inhibitor of sarco/ER Ca 
2+  -ATPase, to measure the 
amount of Ca 
2+   associated with ER-exchangeable intracellular 
Ca 
2+   stores in either ES (  Fig. 4 F  ) or 3T3-L1 (  Fig. 4 H  ) cells. 
To assess the residual amount of Ca 
2+   contained within thapsigar-
gin-insensitive lumenal Ca 
2+   stores, we used the Ca 
2+   ionophore 
ionomycin (  Fig. 4, F and H  ). Measurement of ionomycin- and 
thapsigargin-induced Ca 
2+   discharge from the ER indicated that 
the WT ES cells and calreticulin-defi  cient ES cells expressing 
the P+C domain had higher [Ca 
2+ ] ER   and [Ca 
2+ ] Tot ,  respectively, 
compared with the   crt 
   /       ES cells (  Fig. 4 F  ). To provide yet an-
other measure of ER-releasable Ca 
2+  , we measured thapsigar-
gin-induced Ca 
2+   discharge from the ER versus cytosolic [Ca 
2+ ] 
using the Ca 
2+ -sensitive  fl  uorescent dye fura-2-AM under con-
ditions preventing dye sequestration into the ER (  Mery et al., 
1996  ).   Fig. 4 G   shows that calreticulin-containing WT ES cells 
and calreticulin-defi  cient ES cells expressing the P+C domain 
had higher [Ca 
2+ ] ER   and  [Ca 
2+ ] Cyto  , respectively, in comparison 
to the   crt 
   /       ES cells. Similar to the ES cells, overexpression of 
  Figure 6.       PPAR    2 localization in calreticulin-deﬁ  cient G45 and calreticulin-expressing CGR8 ES cells.   At D20 of differentiation, the cells were labeled 
for PPAR    2 and propidium iodide (PI) to identify the nuclei as described in Materials and methods. (A) In the calreticulin-deﬁ  cient cells, PPAR    2 (green) 
colocalized with propidium iodide (red). (B) In the calreticulin-containing cells, labeling for PPAR    2 was barely detectable and perinuclear. Bar, 25   μ  m.     JCB • VOLUME 182 • NUMBER 1 • 2008  110111 CALRETICULIN MODULATES ADIPOGENIC COMMITMENT   • Szabo et al. 
increased adipogenesis), PPAR  2 was distinctly nuclear ( Fig. 6 A ). 
However, in the WT ES cells, PPAR    2 was barely detect-
able and appeared cytosolic (  Fig. 6 B  ). Given that the WT ES 
cells show reduced adipogenesis and, thus, only sparse adipo-
cyte colonies,   Fig. 6 B   represents a region of low adipogenic 
potential that predominates in WT outgrowths. Localization of 
C/EBP     was also investigated in the ES cells, and it showed an 
essentially identical pattern to that observed for PPAR   2  (un-
published data). 
  Calmodulin/CaMKII, CREB, and calcineurin 
during adipogenesis 
 Calmodulin – Ca 
2+  /calmodulin-dependent protein kinase II 
(CaMKII) and cAMP response element binding (CREB path-
ways affect adipogenesis (  Wang et al., 1997  ;   Reusch et al., 
2000  ). Western blot analysis with anti-Thr286  –  phosphorylated 
CaMKII, anticalmodulin, and anti-Ser133  –  phosphorylated CREB 
antibodies showed that their expression was higher in calreticu-
lin-defi  cient G45  crt  
   /     and  L7 crt 
   /       cells than in WT and L7 
cells at the end of the 20 d of differentiation (  Fig. 7, A and B  ). 
These results indicate that CaMKII and CREB play a positive role 
during adipogenesis of   crt  
   /     cells and that they are up-regulated 
in the absence of calreticulin. 
  To elucidate the role of the CaMKII pathway, we used 
specifi  c inhibitors of CaMKII, KN-62 and KN-93 (  Hidaka and 
Kobayashi, 1994  ). Inhibition of CaMKII in G45  crt  
   /     and 
L7  crt  
   /     cells with either KN-62 or KN-93 decreased adipo-
genesis (  Fig. 7, C and D  ). Inhibition of CaMKII also resulted 
in the decreased expression of PPAR   2,  C/EBP   , and aP2 in 
all cell lines, with the most dramatic effects in calreticulin-
defi  cient cells (  Fig. 7, E and F  ). KN-92, an inactive analogue 
of KN-93, did not alter oil red O staining (  Fig. 7, C and D  ) or 
adipogenic marker expression in either   crt 
   /       or calreticulin-
containing ES cells (  Fig. 7, E and F  ). These data suggest that 
the calmodulin  –  CaMKII pathway plays an important role dur-
ing adipogenesis from ES cells. 
  Calcineurin is a negative regulator of adipogenesis (  Neal 
and Clipstone, 2002  ;   Kennell and MacDougald, 2005  ) and is 
known to affect calcineurin activity (  Guo et al., 2002  ;   Lynch 
et al., 2005  ). On D20, calcineurin activity was signifi  cantly 
higher in the WT ES cells than in the calreticulin-defi  cient cells 
(  Fig. 7 G  ). In the 3T3-L1 preadipocytes, inhibition of calcineu-
rin with cyclosporin-A promoted adipogenesis (  Fig. 7, H and I  ), 
whereas constitutive expression of activated calcineurin decreased 
adipogenesis (  Fig. 7, H and I  ). These data give support for the 
promoterless control plasmids showed no detectable luciferase 
activity (unpublished data). This fi  nding indicates that PPAR    
activates transcription of the calreticulin gene. 
  To identify the PPAR    -binding site on the calreticulin 
promoter, we performed reporter gene assay with calreticulin 
promoter deletions and mutations (  Fig. 5, B and C  ). Deletion 
of PPRE1 and PPRE2 sites (pLC2 vector) completely abol-
ished PPAR    -dependent activation of the calreticulin pro-
moter (  Fig. 5 B  ). Deletion of PPRE site 2 at     1,944 bp (  Fig. 5 A  ) 
or mutation of PPRE site 1 or 2 (  Fig. 5 A  ) had no effect on 
PPAR     activation of the promoter (  Fig. 5, B and C  ). Thus, 
upon induction of adipogenesis with RA, RXR and PPAR    
form a complex, which binds PPRE sites 1 and 2 on the calre-
ticulin promoter and transcriptionally activates the calreticu-
lin gene. 
  To further elucidate a physical interaction between the 
calreticulin promoter and PPAR    , an electrophoretic mobility 
shift assay (EMSA) was performed (  Fig. 5 C  ). Synthetic oligo-
deoxynucleotides corresponding to PPRE sites 1 and 2 were 
used along with a positive control probe, an ideal PPAR site. 
  Fig. 5 C   shows that the PPAR    – RXR    complex  bound  to 
PPRE1 and PPRE2. This DNA  –  protein interaction was only ob-
served in the presence of RXR    , indicating that PPAR     is  only 
functional once complexed with RXR     ( Fig.  5  C ). The  specifi  c-
ity of the PPRE and PPAR    – RXR    binding was confi  rmed by 
reduced signal intensity after the addition of 30-fold excess of 
cold probe (  Fig. 5 C  ). The lesser intensity in PPRE1 and PPRE2 
complexes (  Fig. 5 C  , lanes 4 and 6) when compared with com-
plexes containing the ideal PPRE site (  Fig. 5 C  , lanes 1, 3, and 
10) is likely the result of the different nucleotide sequences of 
these probes. Specifi  city of the binding was further confi  rmed 
by supershift EMSA and mutation of both PPRE sites (  Fig. 5 D  ). 
Chromatin immunoprecipitation (ChIP) was also performed to 
determine whether there was a direct interaction between the 
calreticulin promoter and PPAR    . ChIP analysis indicated that 
PPAR     bound to both PPRE sites 1 and 2 on the calreticulin 
promoter (  Fig. 5 E  ). We concluded that the PPAR    – RXR   
complex binds to calreticulin PPRE1 and PPRE2 sites and acti-
vates the calreticulin gene. 
 PPAR   2, along with C/EBP    , directly affect gene tran-
scription in the nucleus (  Rosen, 2005  ;   Rosen and MacDougald, 
2006  ). Given that PPAR    2 is both necessary and suffi  cient for 
adipogenesis (  Rosen et al., 2000  ), we determined its spatial ex-
pression during adipogenesis in our ES cell system (  Fig. 6  ). 
On D20 of differentiation in the   crt  
   /     ES cells (which exhibit 
  Figure 7.       Calmodulin, CaMKII, and CREB expression is up-regulated in calreticulin-deﬁ  cient ES cells.   (A) The G45  crt   
    /      and L7  crt   
    /      cells had increased 
calmodulin, phosphorylated CaMKII (Thr286), and phosphorylated CREB (pSer133) expression when compared with WT and L7 cells. (B) Quantitative 
analysis of the expression of calmodulin, CaMKII, and CREB (P   <   0.01;   n   = 6). (C) 10   μ  M KN-62 and KN-93 reduced oil red O staining in calreticulin-null 
(G45  crt   
    /      and L7  crt   
    /     ) cells. Treatment of cells with KN-92, an inactive analogue of KN-93, had no effect on oil red O staining. (D) Colorimetric analysis 
showed a signiﬁ  cant decrease in oil red O staining in calreticulin-null cells upon CaMKII inhibition (P   <   0.01;   n   = 6). (E) Western blot analysis of PPAR    2, 
C/EBP    , and aP2 after inhibition of CaMKII showed lower expression of adipogenic markers than in the untreated cells. Treatment of cells with KN-92 had 
no effect on PPAR    2 and C/EBP     expression. (F) Quantitative analysis of the expression of PPAR    2, C/EBP    , and aP2 levels after CaMKII inhibition (P   <   
0.01;   n   = 6). Calcineurin activity is higher in WT ES cells than in calreticulin-deﬁ  cient cells. (G) At D20, calcineurin activity is higher in WT ES cells than 
either in calreticulin-deﬁ  cient (G45  crt   
    /     ) cells or undifferentiated ES cells at D0 (  n   = 4; P   <   0.01). (H) Inhibition of calcineurin with cyclosporin A (CsA) 
increased oil red O staining in 3T3-L1 cells, whereas expression of constitutively active calcineurin decreased oil red O staining. (I) Colorimetric assay 
of oil red O staining in the 3T3-L1 cells treated as in H (  n   = 6). 3T3-L1, control; 3T3-L1 + CsA, CsA-treated preadipocytes; 3T3-L1 + CaN, 3T3-L1 cells 
overexpressing constitutively active calcineurin (CaN). Error bars represent SD.     
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role of calcineurin in adipogenesis of both ES cells and 3T3-L1 
preadipocytes. The present fi  ndings are consistent with earlier 
studies relating activation of calcineurin to the presence of cal-
reticulin (  Lynch and Michalak, 2003  ;   Lynch et al., 2005  ). 
  Discussion 
  In this study, we show that calreticulin affects adipocyte differ-
entiation from either ES cells or 3T3-L1 preadipocytes. The ab-
sence of calreticulin sways ES cell differentiation toward the 
adipocyte lineage. This choice of fate is reversed to the WT pheno-
type by overexpression of calreticulin or by the Ca 
2+ -buffering 
domain of calreticulin but not by expression of the chaperoning 
  domain of the protein. These effects of calreticulin are likely 
mediated through its Ca 
2+   regulatory function. In comparison to 
WT cells, calreticulin-defi  cient ES cells have reduced ER Ca 
2+  
storage capacity, resulting in reduced ER Ca 
2+   release  upon 
stimulation. Expression of full-length calreticulin or the calre-
ticulin Ca 
2+  -buffering domain in ES cells or 3T3-L1 cells in-
creases ER Ca 
2+   content and reduces the commitment of these 
cells to adipogenesis. In WT cells, chelating cytoplasmic [Ca 
2+ ] 
enhances adipogenesis, and, conversely, increasing cytoplasmic 
[Ca 
2+  ] inhibits adipogenesis. These Ca 
2+   effects may negatively 
affect Ca 
2+  -dependent transcriptional pathways that are required 
for adipogenesis. Calreticulin exerts its Ca 
2+   effects within the 
fi  rst 3 d of differentiation, as manipulation of intracellular [Ca 
2+ ] 
at later stages of differentiation (i.e., D7 or D9) did not alter the 
respective adipogenic potential of ES cells (unpublished data). 
This is consistent with what has been done to elicit calcium-
dependent effects during ES cell differentiation by   Li et al. (2002)  , 
who used 100 nm ionomycin at D4, and   Grey et al. (2005)  , who 
used 100 nm ionomycin at D6. Interestingly,   Li et al. (2002)   
showed that ionomycin could be used at concentrations of 10  –
  1,000 nM at days 4  –  7 with the same effects. Moreover, as calre-
ticulin levels were increasing during the fi  rst 3 d of differentiation, 
PPAR   2  and  C/EBP    levels were decreasing, implying that the 
effects of calreticulin fall within the commitment and/or initial 
stages of adipogenesis. We conclude that calreticulin may act as 
a Ca 
2+  -dependent molecular switch that negatively regulates 
commitment to adipocyte differentiation by down-regulating 
the expression and transcriptional activation of critical pro-
adipogenic transcription factors. 
  Ca 
2+  -handling module of calreticulin inhibits 
adipogenesis 
  An important fi  nding of this study is that calreticulin, at least in 
part, exerts its effects on adipogenesis via its role as a modulator 
of Ca 
2+   homeostasis.  Ca 
2+   has previously been shown to affect 
adipogenesis of 3T3-L1 preadipocytes (  Shi et al., 2000  ;   Jensen 
et al., 2004  ). For example, 3T3-L1 cells exposed to elevated ex-
ternal Ca 
2+   levels accumulated little or no cytoplasmic lipids and 
showed the diminished expression of PPAR   2,  C/EBP  ,  and  aP2 
(  Jensen et al., 2004  ). Increasing cytoplasmic Ca 
2+   levels by thap-
sigargin also inhibited early stages of adipogenesis (  Shi et al., 
2000  ), all pointing out the importance of Ca 
2+   on adipogenesis. 
Indeed, we show here that an increase in intracellular Ca 
2+  
concentration leads to a decrease in adipocyte differentiation. 
  Conversely, decreasing intracellular Ca 
2+   concentrations  promotes 
adipogenesis of calreticulin-defi  cient ES cells. The relationship 
between calreticulin expression, intracellular Ca 
2+   concentration, 
and adipogenesis implies that calreticulin exerts its effects on 
adipogenesis via its Ca 
2+   homeostatic function. However, the for-
mal proof comes from experiments in which functional modules 
of calreticulin were expressed in calreticulin-defi  cient ES cells. 
Upon expression of calreticulin  ’  s Ca 
2+  -buffering P+C domain, 
adipogenesis was halted, whereas expression of the N+P domain 
had no effect on the progression of adipogenesis. 
 Our  fi  ndings that calreticulin affects the commitment to 
adipocyte differentiation are in line with reports that calreticu-
lin-dependent Ca 
2+   signaling also affects several aspects of the 
differentiation of cardiomyocytes (  Li et al., 2002  ;   Grey et al., 
2005;     Puceat and Jaconi, 2005  ) and human myeloid cells (  Clark 
et al., 2002  ). Interestingly, diminished intracellular Ca 
2+   stores 
attenuate cardiomyogenesis but promote adipogenesis and dif-
ferentiation of myeloid cells. Combined, these fi  ndings imply 
that calreticulin and ER Ca 
2+   must play important roles in a va-
riety of differentiation pathways. Moreover, our data regarding 
timing of the [Ca 
2+  ] manipulations indicate that in adipogenesis, 
as in cardiomyogenesis (  Li et al., 2002  ), there is a calreticulin-
regulated calcium-sensitive step referred to as a checkpoint by 
  Li et al. (2002)  . 
  CaMKII and calcineurin activities are 
crucial for adipogenesis 
  Both CaMKII and calcineurin are Ca 
2+   dependent and have 
been implicated in affecting adipogenesis (  Wang et al., 1997  ; 
  Neal and Clipstone, 2002  ;   Kennell and MacDougald, 2005  ). 
The CaMKII pathway is involved in C/EBP     regulation  and, 
thus, indirectly in PPAR regulation. CaMKII activates CREB, 
which, in turn, activates C/EBP     (  Fajas et al., 2002  ;   Wang et al., 
2003  ;   Zhang et al., 2004  ). CREB plays a role in adipogenesis, 
and, indeed, expression of dominant-negative CREB blocks 
adipogenesis (  Reusch et al., 2000  ;   Klemm et al., 2001  ;   Reusch 
and Klemm, 2002  ;   Fox et al., 2006  ;   Vankoningsloo et al., 2006  ). 
CaMKII is also involved in the activation of PPAR   ( Paez-Pereda 
et al., 2005  ;   Park et al., 2007  ), indicating that the CaMKII pathway 
may be critical during adipogenesis. Once C/EBP   is expressed, 
PPAR     and  C/EBP    regulate each other, thereby promoting 
  adipogenesis (  Rosen, 2005  ). Here, we show that increased levels 
of threonine-phosphorylated CaMKII in calreticulin-defi  cient 
cells correlate with their increased adipogenesis, and inhibition 
of CaMKII attenuates adipogenesis in these cells. In calreticulin-
defi  cient cells, in addition to increased CaMKII activity, cal-
modulin and CREB are also up-regulated, thus explaining the 
elevated adipogenesis in these cells. 
  Given that [Ca 
2+ ] ER   is lower in calreticulin-defi  cient cells, 
the question arises as to how CaMKII activity could be in-
creased in these cells. In calreticulin-defi  cient cells, the level of 
tyrosine phosphorylation, including that of c-Src (  Papp et al., 
2007  ), is higher than in WT cells (  Fadel et al., 1999, 2001  ; 
  Szabo et al., 2007  ). Activated c-Src phosphorylates calmodulin 
on tyrosine 99, thereby increasing the affi  nity of calmodulin for 
CaMKII (  Abdel-Ghany et al., 1990  ;   Benaim and Villalobo, 
2002  ). This phosphorylation event is inhibited by high Ca 
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pression of calreticulin is tightly regulated during adipogenesis, 
and any modifi  cation of this expression infl  uences adipogenesis 
such that aberrant calreticulin expression may lead to a variety 
of cellular pathologies, including obesity and diabetes. 
  Materials and methods 
  Cell culture and adipocyte differentiation 
  G45   crt 
    /        ES cells and the WT ES cell line (CGR8) were derived from J1 
129/Sv mice. To generate the L7 ES cell line, J1 129/Sv ES cells were 
electroporated with a targeting vector containing the calreticulin gene with 
the loxP site inserted in introns 1 and 2 (Fig. S1 A) and maintained on 
mitomycin C  –  treated G-418  –  resistant mouse embryonic ﬁ  broblast feeder 
cells (  Mesaeli et al., 1999  ). Recombinant clones were selected with 
0.2 mg/ml G418 and 2 mM gancyclovir. Several hundred colonies were 
picked after 10 d in selection medium and expanded. The L7 clone was 
selected based on Southern blot analysis and Western blot analysis with 
anticalreticulin antibodies (  Mesaeli et al., 1999  ). Cre recombinase with 
additional mutant estrogen receptor ligand-binding domains (Cre-ER and 
MerCreMer) was used to excise exons 2  –  4 from the calreticulin gene 
(Fig. S1 A). In brief, L7 ES cells were stably transfected with Cre recombinase 
mutant expression vector pANMerCreMER (a gift from J.D. Molkentin, Uni-
versity of Cincinnati, Cincinnati, OH) to generate the L7-Cre cell line. 
To generate L7  crt 
    /       , 10   μ  M 4-hydroxytamoxifen was added to promote 
nuclear translocation and consequently activation of Cre recombinase. 
L7  crt 
    /        contained a truncated and silenced calreticulin gene with inter-
rupted reading frame and no expression of the protein (  Fig. 1 C  ). Calreticu-
lin-deﬁ  cient ES (G45  crt 
    /       ) cell lines expressing N+P and P+C domains of 
the protein were also created and designated G45  crt 
    /        N+P and 
G45  crt 
    /        P+C. 
  Adipocyte differentiation was performed by hanging drop method. 
In brief, 1,000 ES cells in 20-  μ  l drops were placed on the lids of tissue cul-
ture dishes for 2 d. The differentiation medium contained high glucose 
DME (Multicell; Wisent) supplemented with 15% FBS (Multicell; Wisent), 
sodium pyruvate,    L-  glutamine, minimal essential medium nonessential 
amino acids, and     -mercaptoethanol. After 2 d, the aggregated ES cells 
formed EBs, which were ﬂ  oated in differentiation medium supplemented 
with 10 
    7   M RA for an additional 3 d. The EBs were then plated onto tissue 
culture dishes coated with 0.1% gelatin (in PBS) in differentiation medium 
supplemented with 1   μ  g/ml insulin and 2 nM triiodothyronine. The differ-
entiation medium was changed every 2 d for the duration of differentiation 
(15 d). The EBs were then collected for Western blot analysis, RNA isola-
tion, or staining with oil red O. 
  Mouse embryonic fibroblasts were isolated from calreticulin-
deﬁ  cient (K42) and WT embryos (K41) as previously described (  Nakamura 
et al., 2000  ). The 3T3-L1 preadipocyte cells were cultured in DME supple-
mented with 10% bovine growth serum at 37  °  C. For adipocyte differentia-
tion, 2-d postconﬂ  uent cells were cultured for 2 d in differentiation medium 
containing 1   μ  M dexamethasone, 0.5 mM methylisobutylxanthine, 5   μ  g/ml 
insulin, and 0.5   μ  M rosiglitazone (Cayman Chemical). Afterward, the 2-d 
insulin (5   μ  g/ml) and 0.5   μ  M rosiglitazone were added. At day 9 of differ-
entiation, the cells were harvested for Western blot analysis, RNA isola-
tion, or staining with oil red O. 
  Plasmid DNA and transfections 
  pSG5-rRxR     and pSG5-mPPAR    2 were gifts from R. Rachubinski (University 
of Alberta, Edmonton, Alberta, Canada). Plasmid DNA was puriﬁ  ed using 
Mega plasmid preparation and columns (QIAGEN) as recommended by 
the manufacturer. Expression vectors encoding the HA-tagged N+P do-
main (pcDNA3.1_Zeo-CRTNPd-1) and P+C domain (pcDNA3.1_Zeo-CRT-
PCd-3) of calreticulin were previously described (  Nakamura et al., 2001  ). 
ES cells were electroporated with 30   μ  g/cuvette of pcDNA3.1_Zeo-CRT-
NPd-1 or pcDNA3.1_Zeo-CRTPCd-3 expression vector by electroporation 
(1,500 V/cm; 25 IxF), and Zeocin (30   μ  g/ml)-resistant clones were iso-
lated. Expression of the recombinant N+P and P+C domains was moni-
tored with anti-HA antibodies (  Nakamura et al., 2001  ). 
  3T3-L1 cells were stably transfected with pcDNA3.1-CRT (encoding 
HA-tagged full-length calreticulin), pcDNA3.1_Zeo-CRTNPd-1, or 
pcDNA3.1_Zeo-CRTPCd-3 using Lipofectamine reagent (Invitrogen) ac-
cording to the manufacturer  ’  s instructions. 3T3-L1 clones expressing full-
length calreticulin or calreticulin domains were selected with 50   μ  g/ml 
Zeocin. Expression of recombinant proteins was monitored with anti-HA 
antibodies (  Nakamura et al., 2001  ). 
concentration (  Fukami et al., 1986  ). Tyrosine-phosphorylated 
calmodulin effectively activates CaMKII (  Corti et al., 1999  ). 
In addition, after initial activation, CaMKII becomes auto-
phosphorylated, remaining active even though its activators are 
removed (  Meyer et al., 1992  ). Therefore, CaMKII may remain 
active and promote adipogenesis in calreticulin-defi  cient cells 
even under reduced intracellular Ca 
2+   concentration. 
  We have found that endogenous calcineurin activity was 
signifi  cantly higher in calreticulin-expressing cells that have 
reduced adipogenic potential compared with the calreticulin-
defi  cient cells that are highly adipogenic. This is in agreement 
with previous studies on calcineurin-dependent inhibition of 
adipogenesis (  Neal and Clipstone, 2002  ;   Kennell and Mac-
Dougald, 2005  ). Thus, we propose that although the calcineurin 
pathway inhibits adipogenesis, the Ca 
2+ -independent  CaMKII 
pathway might be responsible for the promotion of adipogenesis 
in the absence of calreticulin observed here. 
  Calreticulin modulates PPAR     activity 
through a negative feedback mechanism 
 PPAR  2  and  C/EBP    are crucial transcription factors during 
adipogenesis (  Rosen, 2005  ); however, although PPAR   2  is  nec-
essary for adipogenesis to take place (  Rosen et al., 2000  ), C/EBP 
has a more accessory role during this process (  Rosen et al., 
2002  ). We showed here that PPAR    2 and C/EBP     are  down-
regulated in cells overexpressing calreticulin. Therefore, calre-
ticulin may act as a transcriptional regulator of PPAR, whereby 
it inhibits the binding of PPAR/RXR to PPRE in the promoter 
region of the target genes, thus inhibiting transcription activa-
tion by peroxisome proliferators and by fatty acids (  Burns et al., 
1994  ;   Dedhar et al., 1994  ;   Winrow et al., 1995  ). Here, we show 
that the initial process that precedes the effects of calreticulin on 
the activity of the PPAR    – RXR  complex  involves  PPAR    tran-
scriptional activation of the calreticulin gene. PPAR     is a potent 
transcriptional activator of the calreticulin gene as a result of its 
direct interaction with the calreticulin promoter. Thus, PPAR    
can up-regulate calreticulin, and, conversely, calreticulin can 
inhibit its activity. We also found an inverse relationship be-
tween calreticulin and PPAR    2 expression upon induction of 
adipogenesis with RA. RA induces the expression of calreticu-
lin but reduces the expression of PPAR    2. This supports the no-
tion of a hierarchical process in which transcriptional activation 
of the calreticulin gene by PPAR     is the early event followed by 
calreticulin modulation of PPAR   transcriptional activity. These 
data provide evidence for a previously unrecognized negative 
feedback loop whereby PPAR     regulates the expression of 
calreticulin, and calreticulin modulates PPAR   2  activity  and 
expression. This is likely one important mechanism whereby 
calreticulin and ER Ca 
2+   homeostasis regulate adipogenesis. 
  In conclusion, for the fi  rst time, we show an essential role 
for organellar Ca 
2+   in adipogenic regulation. The presence of 
calreticulin inhibits adipogenesis through its effects on Ca 
2+   ho-
meostasis, causing the indirect regulation of crucial pathways 
affecting adipogenesis, such as the calcineurin and CaMKII 
pathways. Although the CaMKII pathway is important for adip-
ogenic differentiation, the calcineurin pathway may be involved 
in other choices of fate of ES cells. Finally, we show that the ex-JCB • VOLUME 182 • NUMBER 1 • 2008  114
GTCCTCGATG-3    ; for C/EBP    , reverse primer 5    -CGCAAGAGCCGA-
GATAAAGC-3     and forward primer 5    -GCGGTCATTGTCACTGGTCA-3    ; 
for aP2, reverse primer 5    -CATCAGCGTAAATGGGGATT-3     and forward 
primer 5    -TCGACTTTCCATCCCACTTC-3    ; and for L32, reverse primer 
5    -CATGGCTGCCCTTCGGCCTC-3     and forward primer 5    -CATTCTCTTC-
GCTGCGTAGCC-3    . PCR products were separated in 1.5% agarose gel. 
The mRNA levels were normalized using L32 as the housekeeping gene, 
and relative mRNA levels were quantiﬁ  ed using ImageJ software. 
  Oil red O staining 
  Before staining with oil red O, cells were washed twice with PBS, ﬁ  xed 
with 10% formaldehyde for 15 min at room temperature, and washed 
twice with distilled water and once with 70% isopropanol. Next, cells were 
stained for 1 h at room temperature with ﬁ  ltered oil red O at a ratio of 60% 
oil red O stock solution (0.5% wt/vol in isopropanol) to 40% distilled wa-
ter. The cells were washed twice with distilled water, twice with PBS, and 
examined under a light microscope. An invertoscope (Diaphot; Nikon) 
equipped with a 10/0.25 DL dry plan Apochromatic objective (Nikon) 
was used for imaging at room temperature. A camera (Coolpix 4500; 
Nikon) was used for image acquisition. For quantitative analysis, oil red O 
was extracted with 5 ml isopropanol for 2 min, and optical density of each 
sample was determined at 540 nm. 
  EMSA 
  Full-length RXR     and PPAR     and luciferase control proteins were synthesized 
using a coupled transcription and translation reticulocyte system (Promega; 
  Guo et al., 2001  ). Synthetic oligodeoxynucleotides corresponding to 
PPAR site 1 (PPRE1; 5    -AGTGTGG  AGGTCAGAGGACA  CCGGCTC-3    ) 
and PPAR site 2 (PPRE2; 5    -TCCTGGC  TGGCCCTTGACCT  TATCCTG-3    ) in 
the calreticulin promoter were used. An ideal PPRE oligodeoxynucleotide 
sequence, 5    -CAAAACT  AGGTCAAAGGTCA  AGGCATC-3    , was used as 
a positive control. Underlined residues correspond to the PPAR-binding 
site. Deoxyoligonucleotides were labeled with     -[ 
32  P]ATP (GE Healthcare) 
using T4 polynucleotide kinase. EMSA was performed as described previ-
ously (  Guo et al., 2001  ). For supershift analysis, anti-HA tag antibodies 
were used. 
  ChIP assay 
  ChIP assay was performed as described previously (  Lynch et al., 2005  ). 
In brief, NIH-3T3 cells were transiently transfected with HA-PPAR     and 
cross-linked in 1% formaldehyde at room temperature for 20 min. Cells 
were then lysed with the Extract-N-Amp kit (Sigma-Aldrich) according to 
the manufacturer  ’  s instructions. Chromatin was sheared by sonication fol-
lowed by centrifugation for 10 min. Supernatants were precleared with 
protein A  –  Sepharose beads for 1 h at 4  °  C. Immunoprecipitation was 
performed with mouse anti-HA antibodies at 4  °  C overnight. DNA was 
puriﬁ  ed and analyzed by PCR using the following primers: PPRE site 1, 
forward primer 5    -TGTGTCTGAAGACAGCTACAGTG-3     and reverse 
primer 5    -GCAGCAGGAGAAAAGAAGAGAG-3    ; PPRE site 2, forward 
primer 5    -  CTCTATGGCCTGAACAACTGTG  -3     and reverse primer 
5    -  TGGTCAGAGGGAAGAAGTAAGG  -3     
  Calcineurin activity assay 
  Calcineurin activity assay was performed as previously described (  Fruman 
et al., 1992)  . In brief, a peptide corresponding to the regulatory domain 
of protein kinase A (Sigma-Aldrich) was used as the substrate in an in vitro 
dephosphorylation assay (RII peptide). 1.0   ×   10 
6   cells were lysed in 50 ml 
hypotonic lysis buffer containing 50 mM Tris, pH 7.5, 0.1 mM EGTA, 
1 mM EDTA, 250 mM DTT, and protease inhibitors. 20 ml of lysate was 
added to 5 mM     -[ 
32  P]  –  labeled RII peptide. The reaction was performed 
for 20 min at 30  °  C in the presence of 0.5 mM okadaic acid with a total re-
action volume of 60 ml. The released phosphate reported the activity of 
calcineurin and was expressed in picomoles of phosphate released per 
milligrams of total protein. 
  Immunoﬂ  uorescence and Nile red staining 
  Cells on coverslips were ﬁ  xed in 3.7% formaldehyde in PBS for 10 min. 
After washing (three times for 5 min) in PBS, the cells were permeabilized 
with 0.1% Triton X-100 in buffer containing 100 mM Pipes, pH 6.9, 1 mM 
EGTA, and 4% (wt/vol) polyethylene glycol 8000 for 2 min, washed three 
times for 5 min in PBS, and incubated with goat polyclonal anti-PPAR    2 
antibody (diluted 1:50 in PBS; Santa Cruz Biotechnology, Inc.) for 30 min 
at room temperature. After washing three times for 5 min in PBS, the cells 
were incubated with the secondary antibody for 30 min at room tempera-
ture. The secondary antibody was FITC-conjugated donkey anti  –  goat 
IgG(H+L) diluted 1:50 in PBS. The cells were then incubated with 0.2 mM 
  Reporter gene assay 
  3T3-NIH cells were cotransfected with reporter plasmid containing the calre-
ticulin promoter, deletion of the calreticulin promoter, or the calreticulin pro-
moter with mutations of PPRE1 or PPRE2 (pLC0, pLC1, pLC2, pLC0mt1, and 
pLC0mt2), PPAR    , and RXR     expression vectors. pLC1 and pLC2 plasmids 
encode the luciferase reporter gene under the control of 1.7-kb and 0.4-kb 
calreticulin promoters, respectively (  Waser et al., 1997  ). pLC0 encoded the 
luciferase reporter gene under control of the 2.1-kb calreticulin promoter 
(  Waser et al., 1997  ). To generate pLC0mt1 and pLC0mt2 plasmids, site-
directed mutagenesis of PPRE1 and PPRE2 of the calreticulin promoter, respec-
tively, was performed using the QuikChange Site-Directed Mutagenesis 
kit (Stratagene). Speciﬁ  cally, PPRE1 (AGGTCAGAGGACA) was mutated to 
AGGctcGAGGAtc, whereas PPRE2 (TGGCCCTTGACCT) was mutated to 
ccGggCTgctCCc (lowercase letters are mutated nucleotides). After 48 h, 
cells were harvested in a lysis buffer containing 100 mM Tris, pH 7.8, 0.5% 
NP-40, and 0.5 mM DTT. Luciferase and     -galactosidase activity were mea-
sured as described previously (  Waser et al., 1997  ). 
  Inhibitor studies 
  At the ﬂ  oating stage (days 3  –  5 of differentiation), EBs were incubated with 
KN-62 CaMK inhibitor or its inactive analogue (KN-93;   Hidaka and 
Kobayashi, 1994  ) at concentrations of 10   μ  M for 2 h during the 3 d of EB 
ﬂ  otation stage. The optimal inhibitory concentrations of KN-62 and KN-93 
were determined to be in the range of 10 to 15   μ  M. Under these condi-
tions, the drugs had no effect on cell survival/proliferation. For inhibition 
of calcineurin, 3T3-L1 preadipocytes were incubated with 1   μ  g/ml cyclo-
sporin-A. The cells were then allowed to differentiate for an additional 15 d 
and were harvested for Western blot analysis, RNA isolation, or staining 
with oil red O. 
  Ca 
2+   studies and measurements 
  The  
45  Ca 
2+   measurements as well as [Ca 
2+  ] measurements using the Ca 
2+  -
sensitive ﬂ  uorescent dye fura-2-AM were performed as previously described 
in detail by   Mery et al. (1996)  . The ionomycin and BAPTA-AM treatment 
regimen was performed as previously described by   Li et al. (2002)   and 
  Grey et al. (2005)   with the following modiﬁ  cations: to obtain the optimal 
functional output, three consecutive pulse treatments were used for either 
ionomycin or BAPTA-AM. To chelate cytoplasmic Ca 
2+  , ﬂ  oating EBs were 
incubated with 50 nM BAPTA-AM for 30 min at days 3  –  5 of differentiation. 
To increase cytoplasmic Ca 
2+  , the EBs were incubated for 2 h with 500 nM 
ionomycin in the same manner. Exposure to ionomycin or BAPTA-AM exerts 
a signiﬁ  cant change even after 1 d of treatment, but optimal results were 
obtained with three pulses of treatment on three consecutive days of differ-
entiation. The cells were then allowed to differentiate on gelatinized 
(0.01%) tissue culture dishes for 15 d, after which they were collected for 
Western blot analysis, RNA isolation, or staining with oil red O. 
  SDS-PAGE and Western blot analysis 
  Cells were harvested in a lysis buffer containing 50 mM Tris-HCl, pH 8.0, 
120 mM NaCl, and 0.5% NP-40. Protein concentration was determined 
by the method of Bradford (  Bradford, 1976  ). Protein samples (10   μ  g per 
lane) were separated by SDS-PAGE and transferred to nitrocellulose mem-
brane (  Nakamura et al., 2001  ). Western blot analysis was performed 
with the following antibodies: anti-PPAR    2 (Sigma-Aldrich and Santa Cruz 
Biotechnology, Inc.) at 1:1,000 dilution; anticalreticulin (  Opas et al., 
1991  ) at 1:300 dilution; anti-C/EBP     (Santa Cruz Biotechnology, Inc.) 
at 1:1,000 dilution; anti  –  glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH; Labfrontiers) at 1:5,000 dilution; anti-CaMKII (Afﬁ   nity Bio-
Reagents) at 1:1,000 dilution; antiphospho-CaMKII Thr286 (Invitrogen) at 
1:500 dilution; anticalmodulin (Afﬁ  nity BioReagents) at 1:1000 dilution; 
and anti-CREB pSer133 (Sigma-Aldrich) at 1:1,000 dilution. All second-
ary antibodies were horseradish peroxidase conjugated (Jackson Immuno-
chemicals) and were used at 1:100,000 dilution. Immunoreactive bands 
were detected with a chemiluminescence ECL Western blotting system 
(GE Healthcare). Western blots were normalized by using anti-GAPDH 
antibodies. Relative mRNA levels were normalized to the housekeeping 
gene L32. Bands were quantiﬁ  ed using ImageJ software (National Institutes 
of Health). 
  RNA preparation and RT-PCR analysis 
  Total RNA was isolated from cells grown in 10-cm tissue culture dishes 
using TRIzol reagent (Invitrogen) according to the manufacturer  ’  s instruc-
tions. 1   μ  g RNA was used for synthesis of cDNA followed by RT-PCR using 
Superscript II (Invitrogen) according to the manufacturer  ’  s protocol. The 
following primers were used for PCR analysis: for PPAR    , forward primer 
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ribonuclease A (Sigma-Aldrich) for 2 h at room temperature to digest RNA 
and washed in PBS (three times for 5 min) followed by incubation with 
1   μ  l/ml propidium iodide in PBS for 30 min to identify nuclei. For Nile red 
staining, the dye stock solution of 0.5 mg/ml in acetone was diluted in a 
glycerol/PBS mixture (0.05 ml of Nile red stock solution in 1 ml of 3:1 
glycerol/PBS). Cells were ﬁ  xed and permeabilized as for immunoﬂ  uores-
cence and incubated with Nile red working solution for 10 min. After the 
ﬁ  nal wash (three times for 5 min in PBS), the slides were mounted in ﬂ  uo-
rescent mounting medium (to prevent photobleaching; Dako). A confocal 
ﬂ  uorescence microscope (MRC 600; Bio-Rad Laboratories) equipped with 
a 60/1.40 plan Apochromatic oil immersion objective (Nikon) and a kryp-
ton/argon laser was used for ﬂ  uorescence imaging at room temperature. 
COMOS software (Bio-Rad Laboratories) was used for image acquisition. 
  Statistical analysis 
  Differences between mean values for different treatments were calculated 
using analysis of variance or two-tailed unpaired   t   test (where applicable) 
and were considered to be signiﬁ  cant at P   <   0.05 and P   <   0.01. 
  Online supplemental material 
  Fig. S1 shows genomic conﬁ  guration of the calreticulin gene. Fig. S2 
shows nucleotide sequence of the calreticulin promoter. Online supple-
mental material is available at http://www.jcb.org/cgi/content/full/jcb
.200712078/DC1. 
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